PixarBio Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. PixarBio recent Real Value cannot be determined due to lack of data. The prevailing price of PixarBio is $0.0. Our model determines the value of PixarBio from analyzing the company fundamentals such as EBITDA of (11.22 M), price to earning of (1.38) X, and Current Valuation of (515.1 K) as well as examining its technical indicators and probability of bankruptcy.
PixarBio Total Value Analysis
PixarBio is at this time projected to have valuation of (515.1 K) with market capitalization of 81, debt of 309.67 K, and cash on hands of 715.11 K. The negative valuation of PixarBio may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the PixarBio fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(515.1 K) | 81 | 309.67 K | 715.11 K |
PixarBio Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of PixarBio suggests not a very effective usage of assets in January.PixarBio Ownership Allocation
PixarBio owns a total of 81.51 Million outstanding shares. PixarBio holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.12 pct. of PixarBio outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PixarBio Profitability Analysis
Net Loss for the year was (5.95 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PixarBio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PixarBio and how it compares across the competition.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in PixarBio Stock
If you are still planning to invest in PixarBio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PixarBio's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |